Page 9 - Controlled Release News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Efficient boron neutron capture therapy for brain tumor with novel boron carrier

Efficient boron neutron capture therapy for brain tumor with novel boron carrier
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Hiroyuki nakamuraKai nishimuraTokyo institute of technology techProfessor hiroyuki nakamuraTokyo instituteTokyo techControlled release

Global Medical Devices Market to Reach $827 88 Billion in 2032: Increasing investment in R&D activities Drives Growth

/PRNewswire/ The "Medical Devices Market Size, Share & COVID-19 Impact Analysis, By Type (Drug Delivery Devices, Diagnostic Devices, By Application, By.

United statesSiemens healthineersLaura woodWorld health organizationBoston scientific corporationRoche ltdNational centerPorter five forces analysisInternational diabetes federationGe healthcareSmith nephewAmerican cancer societyOffice hours callAbbott laboratories incE st office hours callCompany profiles

Avicanna and Medipharm Labs Expand Strategic Manufacturing Agreement for Avicanna s Proprietary SEDDS Technology Capsules for Canadian and International markets

Avicanna and Medipharm Labs Expand Strategic Manufacturing Agreement for Avicanna s Proprietary SEDDS Technology Capsules for Canadian and International markets
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesAshish kumarAvicanna mymediIslam ahmed hamedIvana maricAvicanna incTechnology capsules for canadianMedipharm labs incMedipharm labsSelf emulsifying drug delivery systemsAras azadianGood production practicesStrategic manufacturing agreementGood manufacturing practicesLeveraging avicannaCannabis care portal

PureTech Initiates Phase 2a Clinical Trial of LYT-300 (Oral Allopregnanolone) for the Potential Treatment of Anxiety Disorders

PureTech Initiates Phase 2a Clinical Trial of LYT-300 (Oral Allopregnanolone) for the Potential Treatment of Anxiety Disorders
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesChristopher porterPuretech glyphEric elenkoRob winderBen atwellAngewandte chemieNichole sarkisPorter research groupPuretech healthDrug administrationTech healthChief innovation officerUnited states foodMonash institutePharmaceutical sciences

Nanoparticle used to deliver brain cancer drug

The new silica nanoparticle can be loaded with temozolomide, a small molecule drug used to treat tumours known as glioblastoma.

Taskeen janjuaAmirali popatUniversity of queenslandCancer australiaControlled releaseAssociate professor amirali popatUniversity of queenslandBrain cancerBrain tumourOurnal of controlled release